Dr. Lawrence Fong, based in San Francisco, California, did his medical school from the Stanford University School of Medicine. He pursued a residency in internal medicine at the University of Washington and a fellowship in medical oncology at the Stanford University. He is a board-certified oncologist and has been in practice for more than two decades. Currently, Dr. Fong practices at the UCSF Medical Center and San Francisco General Hospital. He has also contributed to three research publications.
University of Washington
American Board of Internal Medicine - Oncology
Prospects for the use of ipilimumab in treating advanced prostate cancer.
Wei, X. X.,Fong, L.,Small, E. J.; Expert Opin Biol Ther. 2015 Dec 25.See more >>
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
Wei, X. X.,Fong, L.,Small, E. J.; Expert Rev Vaccines. 2015 Oct 22.See more >>
A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer.
Small, E. J.,Lance, R. S.,Gardner, T. A.,Karsh, L. I.,Fong, L.,McCoy, C.,DeVries, T.,Sheikh, N. A.,GuhaThakurta, D.,Chang, N.,Redfern, C. H.,Shore, N. D.; Clin. Cancer Res.. 2015 May 01.See more >>